Home-based cardiac rehabilitation with family support for heart attack patients
Tests home cardiac rehabilitation with family involvement in adults recovering from acute coronary syndrome.
Plain-language title generated from the registry record
Registry title: Development and Implementation Model of Home Based Cardiac Rehabilitation With Family Empowerment Approach in Patient With ACS (HBCR in ACS)
Key facts
- Where
- Sleman and Yogyakarta, IndonesiaSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT06625463, who can take part
Where in Indonesia
- Gadjah Mada UniversitySleman, IndonesiaNot yet recruiting
- Rsup Dr SardjitoYogyakarta, IndonesiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Gadjah Mada University
- Trial code
- NCT06625463
- Record updated
- 15 June 2025
- Original description
The aim of this clinical trial is to determine whether home-based cardiac rehabilitation with a family empowerment approach can help acute coronary syndrome patients recover. The main questions to be answered are:Read full original descriptionShow less
Development and Implementation Model of Home Based Cardiac Rehabilitation With Family Empowerment Approach in Patient With ACS (HBCR in ACS)
The aim of this clinical trial is to determine whether home-based cardiac rehabilitation with a family empowerment approach can help acute coronary syndrome patients recover. The main questions to be answered are:
- Does home-based cardiac rehabilitation with a family approach effective in patients with acute coronary syndrome to improve health-related quality of life and peak Vo2? Researchers will compare with usual care to see if home-based cardiac rehabilitation with a family approach is more effective for improving health-related quality of life and peak Vo2 in ACS patients.
Patient inclusion criteria
1. Patients with acute coronary syndrome who had undergone hospitalization, with a minimum home care time of 3 months and a maximum of 1 year, calculated from the day of discharge from the hospital until the time of the interview. 2. Aged 18-65 years old, participants were selected with age variations representing young adults, adults and the elderly. 3. Patients with first experience of SCA, participants were selected whether they had undergone PCI or not. 4. Patients living with family and family involved in the patient care process. 5. Physical condition allows for interviews. physical condition is evidenced by examination of stable vital signs (diastolic BP
\>90, systolic \<150 mmhg; N: 60-100x/min; S: 36-380c, no pain). Psychological condition does not show symptoms of depression as measured by the Patient Health Questionnaire-9 instrument. 6. Willing to participate in the study.
Participants will:
For 12 weeks
1. Perform walking exercises as prescribed 2. Implement diets and stress management according to the module 3. Quit smoking 4. Medication compliance 5. visit the clinic to see a cardiologist, undergo a 6-minute walk test
Inclusion: Patients with acute coronary syndrome who have undergone hospitalization, with a minimum home care time of 3 months and a maximum of 1 year, calculated from the day of discharge from the hospital until the time of interview; Aged 18-65 years, participants were selected with age variations representing young adults, adults and the elderly; Patients with first experience of SCA, participants were selected whether they had undergone PCI or not; Patients living with family and family involved in the patient care process; Physical condition allows for interviews. physical condition is evidenced by examination of stable vital signs (diastolic BP; \>90, systolic \<150 mmhg; N: 60-100x/min; S: 36-380c, no pain). Psychological condition does not show symptoms of depression as measured by the Patient Health Questionnaire-9 instrument; Willing to participate in the study.
Exclusion: Patients with comorbidities that require routine medication such as Diabetes Mellitus, hypertension, renal failure.